WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS
New partnerships and contracts expected to bring in $1 million in near-term R&D/milestone revenue and generate long term commercial revenue Sunnyvale, California – August 8, 2023 – Willow Biosciences Inc. (“Willow“) (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable functional ingredients, today released its financial and operating […]
WILLOW BIOSCIENCES TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON AUGUST 9
President and CEO Dr. Chris Savile to provide business update at event open to all investors SUNNYVALE, California – August 2, 2023 – Willow Biosciences Inc.(“Willow“) (TSX: WLLW; OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients announces that it will present at the upcoming Emerging Growth […]
WILLOW AND KALSEC ADVANCE DEVELOPMENT PROGRAM FOR NEW NATURAL FUNCTIONAL INGREDIENT FOR SAVORY FOODS
Program further validates Willow’s technology and focus on commercial execution and aligns with its strategic focus on near term revenue generation Kalamazoo, Michigan and Sunnyvale, California – July 20, 2023 – Willow Biosciences Inc. (“Willow“) (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients, and Kalsec® […]
WILLOW BIOSCIENCES TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON JUNE 14
President and CEO Dr. Chris Savile to provide business update at event open to all investors Mountain View, California – June 7, 2023 – Willow Biosciences Inc.(“Willow“) (TSX: WLLW; OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients announces that it has been invited to present at […]
WILLOW SIGNS MASTER SERVICES AGREEMENT WITH INNOVATIVE BIOTECH COMPANY TO DEVELOP INGREDIENTS FOR AGE-RELATED DISEASES
Biotech partner recognizes strength of Willow’s first in class FutureGrownTM technology platform for producing natural products Further expansion and diversification of Willow’s product portfolio with collaboration revenue expected in 2023 and potential for near-term commercial product revenue Mountain View, California – May 31, 2023 – Willow Biosciences Inc.(“Willow“) (TSX: WLLW; OTCQB: CANSF), a leading biotechnology company […]
KALSEC AND WILLOW BIOSCIENCES TO DEVELOP NOVEL ENZYME FOR PRODUCTION OF AN ADVANCED BEVERAGE INGREDIENT
Rapid success of first collaboration leads to partnership on high-value specialty ingredient Enzyme development expected to enable commercial-scale production in 2024 Kalamazoo, Michigan and Mountain View, California – May 23, 2023 – Willow Biosciences Inc. (“Willow“) (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients and […]